VRTX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	993,800,000
Mar 31, 2026	961,600,000
Dec 31, 2025	973,700,000
Sep 30, 2025	1,032,200,000
Jun 30, 2025	978,400,000
Mar 31, 2025	979,700,000
Dec 31, 2024	998,700,000
Sep 30, 2024	875,900,000
Jun 30, 2024	5,415,700,000
Mar 31, 2024	865,900,000
Dec 31, 2023	1,351,700,000
Sep 30, 2023	861,700,000
Jun 30, 2023	896,200,000
Mar 31, 2023	742,600,000
Dec 31, 2022	694,100,000
Sep 30, 2022	645,000,000
Jun 30, 2022	600,100,000
Mar 31, 2022	603,100,000
Dec 31, 2021	694,300,000
Sep 30, 2021	493,751,000
Jun 30, 2021	1,407,090,000
Mar 31, 2021	455,973,000
Dec 31, 2020	466,584,000
Sep 30, 2020	493,497,000
Jun 30, 2020	420,928,000
Mar 31, 2020	448,528,000
Dec 31, 2019	480,011,000
Sep 30, 2019	555,948,000
Jun 30, 2019	379,091,000
Mar 31, 2019	339,490,000
Dec 31, 2018	437,881,000
Sep 30, 2018	330,510,000
Jun 30, 2018	337,532,000
Mar 31, 2018	310,553,000
Dec 31, 2017	306,664,000
Sep 30, 2017	454,947,000
Jun 30, 2017	289,451,000
Mar 31, 2017	273,563,000
Dec 31, 2016	248,452,000
Sep 30, 2016	275,370,000
Jun 30, 2016	271,008,000
Mar 31, 2016	255,860,000
Dec 31, 2015	310,429,000
Sep 30, 2015	246,284,000
Jun 30, 2015	223,858,000
Mar 31, 2015	215,599,000
Dec 31, 2014	201,463,000
Sep 30, 2014	190,939,000
Jun 30, 2014	224,780,000
Mar 31, 2014	238,963,000
Dec 31, 2013	249,609,000
Sep 30, 2013	228,567,000
Jun 30, 2013	222,455,000
Mar 31, 2013	218,095,000
Dec 31, 2012	213,109,000
Sep 30, 2012	200,161,000
Jun 30, 2012	196,544,000
Mar 31, 2012	196,371,000
Dec 31, 2011	186,438,000
Sep 30, 2011	189,052,000
Jun 30, 2011	172,796,000
Mar 31, 2011	158,612,000
Dec 31, 2010	168,888,000
Sep 30, 2010	170,434,000
Jun 30, 2010	155,082,000
Mar 31, 2010	143,012,000
Dec 31, 2009	135,230,000
Sep 30, 2009	132,132,000
Jun 30, 2009	139,331,000
Mar 31, 2009	143,581,000
Dec 31, 2008	144,610,000
Sep 30, 2008	129,968,000
Jun 30, 2008	127,132,000
Mar 31, 2008	114,582,000
Dec 31, 2007	115,340,000
Sep 30, 2007	128,949,000
Jun 30, 2007	136,187,000
Mar 31, 2007	132,578,000
Dec 31, 2006	109,146,000
Sep 30, 2006	96,115,000
Jun 30, 2006	91,250,000
Mar 31, 2006	75,202,000
Dec 31, 2005	68,158,000
Sep 30, 2005	63,590,000
Jun 30, 2005	59,357,000
Mar 31, 2005	57,435,000
Dec 31, 2004	54,247,000
Sep 30, 2004	48,790,000
Jun 30, 2004	47,450,000
Mar 31, 2004	41,675,000
Dec 31, 2003	45,772,000
Sep 30, 2003	50,035,000
Jun 30, 2003	50,712,000
Mar 31, 2003	53,117,000
Dec 31, 2002	58,828,000
Sep 30, 2002	50,622,000
Jun 30, 2002	46,546,000
Mar 31, 2002	47,022,000
Dec 31, 2001	44,625,000
Sep 30, 2001	38,116,000